nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—CYP3A4—bone cancer	0.761	1	CbGaD
Fluconazole—Voriconazole—CYP3A4—bone cancer	0.00556	1	CrCbGaD
Fluconazole—CYP11B1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00414	0.0946	CbGpPWpGaD
Fluconazole—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00204	0.0466	CbGpPWpGaD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP4V2—bone cancer	0.00178	0.0407	CbGpPWpGaD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00147	0.0337	CbGpPWpGaD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00114	0.026	CbGpPWpGaD
Fluconazole—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00112	0.0255	CbGpPWpGaD
Fluconazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00104	0.0239	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00104	0.0238	CbGpPWpGaD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00104	0.0237	CbGpPWpGaD
Fluconazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000991	0.0227	CbGpPWpGaD
Fluconazole—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000982	0.0225	CbGpPWpGaD
Fluconazole—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000945	0.0216	CbGpPWpGaD
Fluconazole—CYP2C9—Cisplatin—bone cancer	0.000914	0.275	CbGbCtD
Fluconazole—ABCB1—Cisplatin—bone cancer	0.000887	0.267	CbGbCtD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000876	0.02	CbGpPWpGaD
Fluconazole—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000829	0.019	CbGpPWpGaD
Fluconazole—CYP11B1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000818	0.0187	CbGpPWpGaD
Fluconazole—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00074	0.0169	CbGpPWpGaD
Fluconazole—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.00071	0.0162	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000684	0.0156	CbGpPWpGaD
Fluconazole—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000683	0.0156	CbGpPWpGaD
Fluconazole—CYP11B1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000672	0.0154	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—GNA11—bone cancer	0.000649	0.0149	CbGpPWpGaD
Fluconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000644	0.0147	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000633	0.0145	CbGpPWpGaD
Fluconazole—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00061	0.014	CbGpPWpGaD
Fluconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0006	0.0137	CbGpPWpGaD
Fluconazole—ABCB1—Doxorubicin—bone cancer	0.000594	0.179	CbGbCtD
Fluconazole—ABCB1—Methotrexate—bone cancer	0.000576	0.173	CbGbCtD
Fluconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00056	0.0128	CbGpPWpGaD
Fluconazole—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000549	0.0126	CbGpPWpGaD
Fluconazole—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000528	0.0121	CbGpPWpGaD
Fluconazole—Myalgia—Cisplatin—bone cancer	0.000524	0.00281	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000521	0.00279	CcSEcCtD
Fluconazole—Hot flush—Doxorubicin—bone cancer	0.00052	0.00279	CcSEcCtD
Fluconazole—Discomfort—Cisplatin—bone cancer	0.000518	0.00278	CcSEcCtD
Fluconazole—Menopausal symptoms—Doxorubicin—bone cancer	0.000515	0.00276	CcSEcCtD
Fluconazole—Breast disorder—Methotrexate—bone cancer	0.000507	0.00272	CcSEcCtD
Fluconazole—Face oedema—Epirubicin—bone cancer	0.000507	0.00272	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000505	0.00271	CcSEcCtD
Fluconazole—Purpura—Doxorubicin—bone cancer	0.000504	0.0027	CcSEcCtD
Fluconazole—Anaphylactic shock—Cisplatin—bone cancer	0.000503	0.0027	CcSEcCtD
Fluconazole—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000501	0.0114	CbGpPWpGaD
Fluconazole—Ataxia—Epirubicin—bone cancer	0.000494	0.00265	CcSEcCtD
Fluconazole—Nervous system disorder—Cisplatin—bone cancer	0.000493	0.00264	CcSEcCtD
Fluconazole—Thrombocytopenia—Cisplatin—bone cancer	0.000492	0.00264	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.00049	0.0112	CbGpPWpGaD
Fluconazole—Skin disorder—Cisplatin—bone cancer	0.000488	0.00262	CcSEcCtD
Fluconazole—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000488	0.0112	CbGpPWpGaD
Fluconazole—Hyperhidrosis—Cisplatin—bone cancer	0.000486	0.00261	CcSEcCtD
Fluconazole—Dry skin—Epirubicin—bone cancer	0.000482	0.00258	CcSEcCtD
Fluconazole—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000481	0.011	CbGpPWpGaD
Fluconazole—Anorexia—Cisplatin—bone cancer	0.000479	0.00257	CcSEcCtD
Fluconazole—Hypokalaemia—Epirubicin—bone cancer	0.000478	0.00256	CcSEcCtD
Fluconazole—Breast disorder—Epirubicin—bone cancer	0.000475	0.00255	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000473	0.00254	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000473	0.00254	CcSEcCtD
Fluconazole—Face oedema—Doxorubicin—bone cancer	0.000469	0.00252	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000463	0.00248	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000458	0.00246	CcSEcCtD
Fluconazole—Ataxia—Doxorubicin—bone cancer	0.000457	0.00245	CcSEcCtD
Fluconazole—Neutropenia—Methotrexate—bone cancer	0.000454	0.00243	CcSEcCtD
Fluconazole—Paraesthesia—Cisplatin—bone cancer	0.000451	0.00242	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000446	0.0102	CbGpPWpGaD
Fluconazole—Dry skin—Doxorubicin—bone cancer	0.000446	0.00239	CcSEcCtD
Fluconazole—Hypokalaemia—Doxorubicin—bone cancer	0.000442	0.00237	CcSEcCtD
Fluconazole—Breast disorder—Doxorubicin—bone cancer	0.000439	0.00235	CcSEcCtD
Fluconazole—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000438	0.00235	CcSEcCtD
Fluconazole—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000438	0.00235	CcSEcCtD
Fluconazole—Decreased appetite—Cisplatin—bone cancer	0.000437	0.00234	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Cisplatin—bone cancer	0.000434	0.00233	CcSEcCtD
Fluconazole—Infestation—Methotrexate—bone cancer	0.000433	0.00232	CcSEcCtD
Fluconazole—Infestation NOS—Methotrexate—bone cancer	0.000433	0.00232	CcSEcCtD
Fluconazole—Pain—Cisplatin—bone cancer	0.00043	0.00231	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000429	0.0023	CcSEcCtD
Fluconazole—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000429	0.0023	CcSEcCtD
Fluconazole—Neutropenia—Epirubicin—bone cancer	0.000425	0.00228	CcSEcCtD
Fluconazole—Stomatitis—Methotrexate—bone cancer	0.000422	0.00226	CcSEcCtD
Fluconazole—Feeling abnormal—Cisplatin—bone cancer	0.000414	0.00222	CcSEcCtD
Fluconazole—Hepatobiliary disease—Methotrexate—bone cancer	0.000409	0.00219	CcSEcCtD
Fluconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000408	0.00933	CbGpPWpGaD
Fluconazole—Infestation NOS—Epirubicin—bone cancer	0.000405	0.00217	CcSEcCtD
Fluconazole—Infestation—Epirubicin—bone cancer	0.000405	0.00217	CcSEcCtD
Fluconazole—Agranulocytosis—Methotrexate—bone cancer	0.000404	0.00216	CcSEcCtD
Fluconazole—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000403	0.00921	CbGpPWpGaD
Fluconazole—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000401	0.00215	CcSEcCtD
Fluconazole—Body temperature increased—Cisplatin—bone cancer	0.000397	0.00213	CcSEcCtD
Fluconazole—Stomatitis—Epirubicin—bone cancer	0.000395	0.00212	CcSEcCtD
Fluconazole—Jaundice—Epirubicin—bone cancer	0.000395	0.00212	CcSEcCtD
Fluconazole—Neutropenia—Doxorubicin—bone cancer	0.000393	0.00211	CcSEcCtD
Fluconazole—Pharyngitis—Methotrexate—bone cancer	0.000385	0.00207	CcSEcCtD
Fluconazole—Urinary tract disorder—Methotrexate—bone cancer	0.000384	0.00206	CcSEcCtD
Fluconazole—Hepatobiliary disease—Epirubicin—bone cancer	0.000383	0.00205	CcSEcCtD
Fluconazole—Urethral disorder—Methotrexate—bone cancer	0.000381	0.00204	CcSEcCtD
Fluconazole—Agranulocytosis—Epirubicin—bone cancer	0.000378	0.00203	CcSEcCtD
Fluconazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000377	0.00862	CbGpPWpGaD
Fluconazole—Infestation—Doxorubicin—bone cancer	0.000375	0.00201	CcSEcCtD
Fluconazole—Infestation NOS—Doxorubicin—bone cancer	0.000375	0.00201	CcSEcCtD
Fluconazole—Visual impairment—Methotrexate—bone cancer	0.000374	0.00201	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000371	0.00199	CcSEcCtD
Fluconazole—Hypersensitivity—Cisplatin—bone cancer	0.00037	0.00199	CcSEcCtD
Fluconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00037	0.00845	CbGpPWpGaD
Fluconazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000368	0.00841	CbGpPWpGaD
Fluconazole—Erythema multiforme—Methotrexate—bone cancer	0.000367	0.00197	CcSEcCtD
Fluconazole—Jaundice—Doxorubicin—bone cancer	0.000365	0.00196	CcSEcCtD
Fluconazole—Stomatitis—Doxorubicin—bone cancer	0.000365	0.00196	CcSEcCtD
Fluconazole—Eye disorder—Methotrexate—bone cancer	0.000363	0.00195	CcSEcCtD
Fluconazole—Asthenia—Cisplatin—bone cancer	0.000361	0.00193	CcSEcCtD
Fluconazole—Pharyngitis—Epirubicin—bone cancer	0.000361	0.00193	CcSEcCtD
Fluconazole—Cardiac disorder—Methotrexate—bone cancer	0.00036	0.00193	CcSEcCtD
Fluconazole—Urinary tract disorder—Epirubicin—bone cancer	0.000359	0.00192	CcSEcCtD
Fluconazole—Connective tissue disorder—Epirubicin—bone cancer	0.000357	0.00191	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—CYP3A4—bone cancer	0.000357	0.00816	CbGpPWpGaD
Fluconazole—Urethral disorder—Epirubicin—bone cancer	0.000356	0.00191	CcSEcCtD
Fluconazole—CYP3A4—Doxorubicin—bone cancer	0.000356	0.107	CbGbCtD
Fluconazole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000354	0.0019	CcSEcCtD
Fluconazole—Angiopathy—Methotrexate—bone cancer	0.000352	0.00189	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP3A4—bone cancer	0.000352	0.00805	CbGpPWpGaD
Fluconazole—Immune system disorder—Methotrexate—bone cancer	0.000351	0.00188	CcSEcCtD
Fluconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00035	0.00802	CbGpPWpGaD
Fluconazole—Visual impairment—Epirubicin—bone cancer	0.00035	0.00188	CcSEcCtD
Fluconazole—Mediastinal disorder—Methotrexate—bone cancer	0.00035	0.00188	CcSEcCtD
Fluconazole—Agranulocytosis—Doxorubicin—bone cancer	0.00035	0.00187	CcSEcCtD
Fluconazole—Chills—Methotrexate—bone cancer	0.000348	0.00187	CcSEcCtD
Fluconazole—Diarrhoea—Cisplatin—bone cancer	0.000344	0.00184	CcSEcCtD
Fluconazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000344	0.00786	CbGpPWpGaD
Fluconazole—Erythema multiforme—Epirubicin—bone cancer	0.000344	0.00184	CcSEcCtD
Fluconazole—Alopecia—Methotrexate—bone cancer	0.000343	0.00184	CcSEcCtD
Fluconazole—Mental disorder—Methotrexate—bone cancer	0.00034	0.00182	CcSEcCtD
Fluconazole—Eye disorder—Epirubicin—bone cancer	0.00034	0.00182	CcSEcCtD
Fluconazole—Malnutrition—Methotrexate—bone cancer	0.000338	0.00181	CcSEcCtD
Fluconazole—Flushing—Epirubicin—bone cancer	0.000337	0.00181	CcSEcCtD
Fluconazole—Cardiac disorder—Epirubicin—bone cancer	0.000337	0.00181	CcSEcCtD
Fluconazole—Pharyngitis—Doxorubicin—bone cancer	0.000334	0.00179	CcSEcCtD
Fluconazole—Urinary tract disorder—Doxorubicin—bone cancer	0.000332	0.00178	CcSEcCtD
Fluconazole—Dysgeusia—Methotrexate—bone cancer	0.000331	0.00177	CcSEcCtD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000331	0.00756	CbGpPWpGaD
Fluconazole—Connective tissue disorder—Doxorubicin—bone cancer	0.00033	0.00177	CcSEcCtD
Fluconazole—Angiopathy—Epirubicin—bone cancer	0.00033	0.00177	CcSEcCtD
Fluconazole—Urethral disorder—Doxorubicin—bone cancer	0.00033	0.00177	CcSEcCtD
Fluconazole—Immune system disorder—Epirubicin—bone cancer	0.000328	0.00176	CcSEcCtD
Fluconazole—Mediastinal disorder—Epirubicin—bone cancer	0.000328	0.00176	CcSEcCtD
Fluconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000327	0.00749	CbGpPWpGaD
Fluconazole—Back pain—Methotrexate—bone cancer	0.000327	0.00175	CcSEcCtD
Fluconazole—Chills—Epirubicin—bone cancer	0.000326	0.00175	CcSEcCtD
Fluconazole—Visual impairment—Doxorubicin—bone cancer	0.000324	0.00174	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—BRAF—bone cancer	0.000323	0.00739	CbGpPWpGaD
Fluconazole—Alopecia—Epirubicin—bone cancer	0.000321	0.00172	CcSEcCtD
Fluconazole—Vomiting—Cisplatin—bone cancer	0.00032	0.00171	CcSEcCtD
Fluconazole—Mental disorder—Epirubicin—bone cancer	0.000318	0.00171	CcSEcCtD
Fluconazole—Erythema multiforme—Doxorubicin—bone cancer	0.000318	0.0017	CcSEcCtD
Fluconazole—Rash—Cisplatin—bone cancer	0.000317	0.0017	CcSEcCtD
Fluconazole—Dermatitis—Cisplatin—bone cancer	0.000317	0.0017	CcSEcCtD
Fluconazole—Malnutrition—Epirubicin—bone cancer	0.000316	0.0017	CcSEcCtD
Fluconazole—Eye disorder—Doxorubicin—bone cancer	0.000314	0.00168	CcSEcCtD
Fluconazole—Ill-defined disorder—Methotrexate—bone cancer	0.000314	0.00168	CcSEcCtD
Fluconazole—Anaemia—Methotrexate—bone cancer	0.000312	0.00168	CcSEcCtD
Fluconazole—Cardiac disorder—Doxorubicin—bone cancer	0.000312	0.00167	CcSEcCtD
Fluconazole—Flushing—Doxorubicin—bone cancer	0.000312	0.00167	CcSEcCtD
Fluconazole—Flatulence—Epirubicin—bone cancer	0.000312	0.00167	CcSEcCtD
Fluconazole—Tension—Epirubicin—bone cancer	0.00031	0.00166	CcSEcCtD
Fluconazole—Dysgeusia—Epirubicin—bone cancer	0.00031	0.00166	CcSEcCtD
Fluconazole—Nervousness—Epirubicin—bone cancer	0.000307	0.00165	CcSEcCtD
Fluconazole—Back pain—Epirubicin—bone cancer	0.000306	0.00164	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—GSTP1—bone cancer	0.000305	0.00698	CbGpPWpGaD
Fluconazole—Angiopathy—Doxorubicin—bone cancer	0.000305	0.00164	CcSEcCtD
Fluconazole—Malaise—Methotrexate—bone cancer	0.000305	0.00163	CcSEcCtD
Fluconazole—Immune system disorder—Doxorubicin—bone cancer	0.000304	0.00163	CcSEcCtD
Fluconazole—Vertigo—Methotrexate—bone cancer	0.000304	0.00163	CcSEcCtD
Fluconazole—Mediastinal disorder—Doxorubicin—bone cancer	0.000303	0.00162	CcSEcCtD
Fluconazole—Leukopenia—Methotrexate—bone cancer	0.000303	0.00162	CcSEcCtD
Fluconazole—Chills—Doxorubicin—bone cancer	0.000302	0.00162	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—GSTP1—bone cancer	0.000301	0.00689	CbGpPWpGaD
Fluconazole—Nausea—Cisplatin—bone cancer	0.000299	0.0016	CcSEcCtD
Fluconazole—Alopecia—Doxorubicin—bone cancer	0.000297	0.00159	CcSEcCtD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000295	0.00674	CbGpPWpGaD
Fluconazole—Mental disorder—Doxorubicin—bone cancer	0.000295	0.00158	CcSEcCtD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000294	0.00673	CbGpPWpGaD
Fluconazole—Ill-defined disorder—Epirubicin—bone cancer	0.000294	0.00157	CcSEcCtD
Fluconazole—Convulsion—Methotrexate—bone cancer	0.000293	0.00157	CcSEcCtD
Fluconazole—Malnutrition—Doxorubicin—bone cancer	0.000293	0.00157	CcSEcCtD
Fluconazole—Anaemia—Epirubicin—bone cancer	0.000292	0.00157	CcSEcCtD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000291	0.00666	CbGpPWpGaD
Fluconazole—Agitation—Epirubicin—bone cancer	0.000291	0.00156	CcSEcCtD
Fluconazole—Flatulence—Doxorubicin—bone cancer	0.000288	0.00155	CcSEcCtD
Fluconazole—Myalgia—Methotrexate—bone cancer	0.000288	0.00154	CcSEcCtD
Fluconazole—Tension—Doxorubicin—bone cancer	0.000287	0.00154	CcSEcCtD
Fluconazole—Dysgeusia—Doxorubicin—bone cancer	0.000287	0.00154	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000286	0.00153	CcSEcCtD
Fluconazole—Malaise—Epirubicin—bone cancer	0.000285	0.00153	CcSEcCtD
Fluconazole—Discomfort—Methotrexate—bone cancer	0.000284	0.00152	CcSEcCtD
Fluconazole—Nervousness—Doxorubicin—bone cancer	0.000284	0.00152	CcSEcCtD
Fluconazole—Vertigo—Epirubicin—bone cancer	0.000284	0.00152	CcSEcCtD
Fluconazole—Leukopenia—Epirubicin—bone cancer	0.000283	0.00152	CcSEcCtD
Fluconazole—Back pain—Doxorubicin—bone cancer	0.000283	0.00152	CcSEcCtD
Fluconazole—Anaphylactic shock—Methotrexate—bone cancer	0.000276	0.00148	CcSEcCtD
Fluconazole—Convulsion—Epirubicin—bone cancer	0.000274	0.00147	CcSEcCtD
Fluconazole—Hypertension—Epirubicin—bone cancer	0.000273	0.00146	CcSEcCtD
Fluconazole—Ill-defined disorder—Doxorubicin—bone cancer	0.000272	0.00146	CcSEcCtD
Fluconazole—Nervous system disorder—Methotrexate—bone cancer	0.000271	0.00145	CcSEcCtD
Fluconazole—Anaemia—Doxorubicin—bone cancer	0.000271	0.00145	CcSEcCtD
Fluconazole—Thrombocytopenia—Methotrexate—bone cancer	0.00027	0.00145	CcSEcCtD
Fluconazole—Myalgia—Epirubicin—bone cancer	0.000269	0.00144	CcSEcCtD
Fluconazole—Agitation—Doxorubicin—bone cancer	0.000269	0.00144	CcSEcCtD
Fluconazole—Skin disorder—Methotrexate—bone cancer	0.000268	0.00144	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000267	0.00143	CcSEcCtD
Fluconazole—Hyperhidrosis—Methotrexate—bone cancer	0.000267	0.00143	CcSEcCtD
Fluconazole—Discomfort—Epirubicin—bone cancer	0.000266	0.00143	CcSEcCtD
Fluconazole—Malaise—Doxorubicin—bone cancer	0.000264	0.00142	CcSEcCtD
Fluconazole—Dry mouth—Epirubicin—bone cancer	0.000263	0.00141	CcSEcCtD
Fluconazole—Vertigo—Doxorubicin—bone cancer	0.000263	0.00141	CcSEcCtD
Fluconazole—Anorexia—Methotrexate—bone cancer	0.000263	0.00141	CcSEcCtD
Fluconazole—Leukopenia—Doxorubicin—bone cancer	0.000262	0.0014	CcSEcCtD
Fluconazole—Anaphylactic shock—Epirubicin—bone cancer	0.000258	0.00138	CcSEcCtD
Fluconazole—Convulsion—Doxorubicin—bone cancer	0.000254	0.00136	CcSEcCtD
Fluconazole—Nervous system disorder—Epirubicin—bone cancer	0.000253	0.00136	CcSEcCtD
Fluconazole—Thrombocytopenia—Epirubicin—bone cancer	0.000253	0.00136	CcSEcCtD
Fluconazole—Hypertension—Doxorubicin—bone cancer	0.000253	0.00135	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000251	0.00135	CcSEcCtD
Fluconazole—Skin disorder—Epirubicin—bone cancer	0.000251	0.00134	CcSEcCtD
Fluconazole—Hyperhidrosis—Epirubicin—bone cancer	0.00025	0.00134	CcSEcCtD
Fluconazole—Insomnia—Methotrexate—bone cancer	0.00025	0.00134	CcSEcCtD
Fluconazole—Myalgia—Doxorubicin—bone cancer	0.000249	0.00134	CcSEcCtD
Fluconazole—Paraesthesia—Methotrexate—bone cancer	0.000248	0.00133	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000247	0.00133	CcSEcCtD
Fluconazole—Discomfort—Doxorubicin—bone cancer	0.000246	0.00132	CcSEcCtD
Fluconazole—Anorexia—Epirubicin—bone cancer	0.000246	0.00132	CcSEcCtD
Fluconazole—Somnolence—Methotrexate—bone cancer	0.000245	0.00131	CcSEcCtD
Fluconazole—Dry mouth—Doxorubicin—bone cancer	0.000244	0.00131	CcSEcCtD
Fluconazole—Dyspepsia—Methotrexate—bone cancer	0.000243	0.0013	CcSEcCtD
Fluconazole—Decreased appetite—Methotrexate—bone cancer	0.00024	0.00129	CcSEcCtD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000239	0.00547	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Doxorubicin—bone cancer	0.000239	0.00128	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000238	0.00128	CcSEcCtD
Fluconazole—Fatigue—Methotrexate—bone cancer	0.000238	0.00128	CcSEcCtD
Fluconazole—Pain—Methotrexate—bone cancer	0.000236	0.00126	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000235	0.00126	CcSEcCtD
Fluconazole—Nervous system disorder—Doxorubicin—bone cancer	0.000234	0.00126	CcSEcCtD
Fluconazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000234	0.00125	CcSEcCtD
Fluconazole—Insomnia—Epirubicin—bone cancer	0.000234	0.00125	CcSEcCtD
Fluconazole—Skin disorder—Doxorubicin—bone cancer	0.000232	0.00124	CcSEcCtD
Fluconazole—Paraesthesia—Epirubicin—bone cancer	0.000232	0.00124	CcSEcCtD
Fluconazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000231	0.00124	CcSEcCtD
Fluconazole—Somnolence—Epirubicin—bone cancer	0.00023	0.00123	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000228	0.00521	CbGpPWpGaD
Fluconazole—Anorexia—Doxorubicin—bone cancer	0.000228	0.00122	CcSEcCtD
Fluconazole—Feeling abnormal—Methotrexate—bone cancer	0.000227	0.00122	CcSEcCtD
Fluconazole—Dyspepsia—Epirubicin—bone cancer	0.000227	0.00122	CcSEcCtD
Fluconazole—Gastrointestinal pain—Methotrexate—bone cancer	0.000226	0.00121	CcSEcCtD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000225	0.00515	CbGpPWpGaD
Fluconazole—Decreased appetite—Epirubicin—bone cancer	0.000224	0.0012	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000223	0.0012	CcSEcCtD
Fluconazole—Fatigue—Epirubicin—bone cancer	0.000223	0.00119	CcSEcCtD
Fluconazole—Pain—Epirubicin—bone cancer	0.000221	0.00118	CcSEcCtD
Fluconazole—Constipation—Epirubicin—bone cancer	0.000221	0.00118	CcSEcCtD
Fluconazole—Urticaria—Methotrexate—bone cancer	0.000219	0.00118	CcSEcCtD
Fluconazole—Abdominal pain—Methotrexate—bone cancer	0.000218	0.00117	CcSEcCtD
Fluconazole—Body temperature increased—Methotrexate—bone cancer	0.000218	0.00117	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000218	0.00117	CcSEcCtD
Fluconazole—Insomnia—Doxorubicin—bone cancer	0.000216	0.00116	CcSEcCtD
Fluconazole—Paraesthesia—Doxorubicin—bone cancer	0.000215	0.00115	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—NDUFA12—bone cancer	0.000214	0.00489	CbGpPWpGaD
Fluconazole—Feeling abnormal—Epirubicin—bone cancer	0.000213	0.00114	CcSEcCtD
Fluconazole—Somnolence—Doxorubicin—bone cancer	0.000212	0.00114	CcSEcCtD
Fluconazole—Gastrointestinal pain—Epirubicin—bone cancer	0.000211	0.00113	CcSEcCtD
Fluconazole—Dyspepsia—Doxorubicin—bone cancer	0.00021	0.00113	CcSEcCtD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000208	0.00475	CbGpPWpGaD
Fluconazole—Decreased appetite—Doxorubicin—bone cancer	0.000208	0.00111	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000206	0.00111	CcSEcCtD
Fluconazole—Fatigue—Doxorubicin—bone cancer	0.000206	0.0011	CcSEcCtD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000205	0.00469	CbGpPWpGaD
Fluconazole—Urticaria—Epirubicin—bone cancer	0.000205	0.0011	CcSEcCtD
Fluconazole—Pain—Doxorubicin—bone cancer	0.000204	0.0011	CcSEcCtD
Fluconazole—Constipation—Doxorubicin—bone cancer	0.000204	0.0011	CcSEcCtD
Fluconazole—Abdominal pain—Epirubicin—bone cancer	0.000204	0.00109	CcSEcCtD
Fluconazole—Body temperature increased—Epirubicin—bone cancer	0.000204	0.00109	CcSEcCtD
Fluconazole—Hypersensitivity—Methotrexate—bone cancer	0.000203	0.00109	CcSEcCtD
Fluconazole—Asthenia—Methotrexate—bone cancer	0.000198	0.00106	CcSEcCtD
Fluconazole—Feeling abnormal—Doxorubicin—bone cancer	0.000197	0.00106	CcSEcCtD
Fluconazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000195	0.00105	CcSEcCtD
Fluconazole—Pruritus—Methotrexate—bone cancer	0.000195	0.00105	CcSEcCtD
Fluconazole—Hypersensitivity—Epirubicin—bone cancer	0.00019	0.00102	CcSEcCtD
Fluconazole—Urticaria—Doxorubicin—bone cancer	0.00019	0.00102	CcSEcCtD
Fluconazole—Body temperature increased—Doxorubicin—bone cancer	0.000189	0.00101	CcSEcCtD
Fluconazole—Abdominal pain—Doxorubicin—bone cancer	0.000189	0.00101	CcSEcCtD
Fluconazole—Diarrhoea—Methotrexate—bone cancer	0.000189	0.00101	CcSEcCtD
Fluconazole—Asthenia—Epirubicin—bone cancer	0.000185	0.000993	CcSEcCtD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000185	0.00423	CbGpPWpGaD
Fluconazole—Pruritus—Epirubicin—bone cancer	0.000183	0.000979	CcSEcCtD
Fluconazole—Dizziness—Methotrexate—bone cancer	0.000182	0.000978	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—NT5C3A—bone cancer	0.000177	0.00405	CbGpPWpGaD
Fluconazole—Diarrhoea—Epirubicin—bone cancer	0.000177	0.000947	CcSEcCtD
Fluconazole—Hypersensitivity—Doxorubicin—bone cancer	0.000176	0.000944	CcSEcCtD
Fluconazole—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000176	0.00402	CbGpPWpGaD
Fluconazole—Vomiting—Methotrexate—bone cancer	0.000175	0.00094	CcSEcCtD
Fluconazole—Rash—Methotrexate—bone cancer	0.000174	0.000933	CcSEcCtD
Fluconazole—Dermatitis—Methotrexate—bone cancer	0.000174	0.000932	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000173	0.00396	CbGpPWpGaD
Fluconazole—Headache—Methotrexate—bone cancer	0.000173	0.000927	CcSEcCtD
Fluconazole—Asthenia—Doxorubicin—bone cancer	0.000171	0.000919	CcSEcCtD
Fluconazole—Dizziness—Epirubicin—bone cancer	0.000171	0.000915	CcSEcCtD
Fluconazole—Pruritus—Doxorubicin—bone cancer	0.000169	0.000906	CcSEcCtD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000168	0.00385	CbGpPWpGaD
Fluconazole—Vomiting—Epirubicin—bone cancer	0.000164	0.00088	CcSEcCtD
Fluconazole—Nausea—Methotrexate—bone cancer	0.000164	0.000879	CcSEcCtD
Fluconazole—Diarrhoea—Doxorubicin—bone cancer	0.000163	0.000876	CcSEcCtD
Fluconazole—Rash—Epirubicin—bone cancer	0.000163	0.000873	CcSEcCtD
Fluconazole—Dermatitis—Epirubicin—bone cancer	0.000163	0.000872	CcSEcCtD
Fluconazole—Headache—Epirubicin—bone cancer	0.000162	0.000867	CcSEcCtD
Fluconazole—Dizziness—Doxorubicin—bone cancer	0.000158	0.000847	CcSEcCtD
Fluconazole—Nausea—Epirubicin—bone cancer	0.000153	0.000822	CcSEcCtD
Fluconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000153	0.00349	CbGpPWpGaD
Fluconazole—Vomiting—Doxorubicin—bone cancer	0.000152	0.000814	CcSEcCtD
Fluconazole—Rash—Doxorubicin—bone cancer	0.000151	0.000808	CcSEcCtD
Fluconazole—Dermatitis—Doxorubicin—bone cancer	0.00015	0.000807	CcSEcCtD
Fluconazole—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.00015	0.00344	CbGpPWpGaD
Fluconazole—Headache—Doxorubicin—bone cancer	0.00015	0.000802	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000148	0.00339	CbGpPWpGaD
Fluconazole—Nausea—Doxorubicin—bone cancer	0.000142	0.000761	CcSEcCtD
Fluconazole—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000127	0.0029	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000125	0.00286	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000125	0.00286	CbGpPWpGaD
Fluconazole—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000117	0.00267	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000109	0.00248	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000107	0.00245	CbGpPWpGaD
Fluconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000107	0.00244	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000106	0.00243	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000105	0.00241	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP3A4—bone cancer	9.82e-05	0.00225	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.68e-05	0.00221	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.68e-05	0.00221	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP3A4—bone cancer	8.95e-05	0.00205	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	8.83e-05	0.00202	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.81e-05	0.00202	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NT5C3A—bone cancer	8.72e-05	0.002	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.69e-05	0.00199	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.4e-05	0.00192	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.28e-05	0.00189	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.24e-05	0.00188	CbGpPWpGaD
Fluconazole—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.79e-05	0.00178	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ENO2—bone cancer	7.77e-05	0.00178	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.66e-05	0.00175	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NDUFA12—bone cancer	7.61e-05	0.00174	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.55e-05	0.00173	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.37e-05	0.00168	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.35e-05	0.00168	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—DHFR—bone cancer	7.2e-05	0.00165	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GNA11—bone cancer	6.73e-05	0.00154	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.34e-05	0.00145	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NT5C3A—bone cancer	6.31e-05	0.00144	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP3A4—bone cancer	6.1e-05	0.0014	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.07e-05	0.00139	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NDUFA12—bone cancer	5.88e-05	0.00135	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NDUFA12—bone cancer	5.74e-05	0.00131	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.46e-05	0.00125	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NDUFA12—bone cancer	5.37e-05	0.00123	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTP1—bone cancer	5.22e-05	0.00119	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.05e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.98e-05	0.00114	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NT5C3A—bone cancer	4.88e-05	0.00112	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NT5C3A—bone cancer	4.76e-05	0.00109	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NT5C3A—bone cancer	4.45e-05	0.00102	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.05e-05	0.000926	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.9e-05	0.000893	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ENO2—bone cancer	3.82e-05	0.000874	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—DHFR—bone cancer	3.55e-05	0.000811	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NDUFA12—bone cancer	3.54e-05	0.000809	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.52e-05	0.000805	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GNA11—bone cancer	3.31e-05	0.000758	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP3A4—bone cancer	3e-05	0.000687	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NT5C3A—bone cancer	2.93e-05	0.000671	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.77e-05	0.000633	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ENO2—bone cancer	2.76e-05	0.000632	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PTGS2—bone cancer	2.7e-05	0.000619	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTP1—bone cancer	2.57e-05	0.000588	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—DHFR—bone cancer	2.56e-05	0.000586	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GNA11—bone cancer	2.4e-05	0.000548	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.32e-05	0.000531	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP3A4—bone cancer	2.17e-05	0.000497	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ENO2—bone cancer	2.14e-05	0.000488	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ENO2—bone cancer	2.08e-05	0.000477	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—DHFR—bone cancer	1.98e-05	0.000453	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ENO2—bone cancer	1.95e-05	0.000445	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—DHFR—bone cancer	1.93e-05	0.000442	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTP1—bone cancer	1.86e-05	0.000425	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GNA11—bone cancer	1.85e-05	0.000424	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GNA11—bone cancer	1.81e-05	0.000413	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—DHFR—bone cancer	1.81e-05	0.000413	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GNA11—bone cancer	1.69e-05	0.000386	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000384	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.67e-05	0.000382	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP3A4—bone cancer	1.64e-05	0.000375	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP3A4—bone cancer	1.53e-05	0.00035	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.52e-05	0.000348	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTP1—bone cancer	1.44e-05	0.000328	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTP1—bone cancer	1.4e-05	0.000321	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PTGS2—bone cancer	1.33e-05	0.000304	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTP1—bone cancer	1.31e-05	0.000299	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ENO2—bone cancer	1.28e-05	0.000294	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—DHFR—bone cancer	1.19e-05	0.000272	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GNA11—bone cancer	1.11e-05	0.000255	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PTGS2—bone cancer	9.62e-06	0.00022	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTP1—bone cancer	8.63e-06	0.000197	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PTGS2—bone cancer	7.44e-06	0.00017	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PTGS2—bone cancer	7.26e-06	0.000166	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PTGS2—bone cancer	6.78e-06	0.000155	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PTGS2—bone cancer	4.47e-06	0.000102	CbGpPWpGaD
